Stuart Therapeutics Announces Initial Results of Phase III Clinical Trial for ST-100 …

By /

Results highlight ST-100's potential for fast-acting healing of ocular surface damage caused by Dry Eye Disease, which affects more than 30 …

Source: google.com

Scroll to Top